Clinical

Dataset Information

A Study of the Safety and Tolerance of Three Doses of G17DT in Metastatic Colorectal Cancer


ABSTRACT: This study was designed to investigate the safety and tolerance of three doses (100µg, 200µg, 500µg) of G17DT for the treatment of patients with colorectal cancer.

DISEASE(S): Colorectal Cancer,Colorectal Neoplasms

PROVIDER: 2173519 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR